Ronald Andrews
2019
In 2019, Ronald Andrews earned a total compensation of $2.1M as President and Chief Executive Officer at Oncocyte Corp.
Compensation breakdown
| Option Awards | $1,626,562 |
|---|---|
| Salary | $276,250 |
| Stock Awards | $163,150 |
| Total | $2,065,962 |
Andrews received $1.6M in option awards, accounting for 79% of the total pay in 2019.
Andrews also received $276.3K in salary and $163.2K in stock awards.
Rankings
In 2019, Ronald Andrews' compensation ranked 5,768th out of 13,971 executives tracked by ExecPay. In other words, Andrews earned more than 58.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,768 out of 13,971 | 59th |
Division Manufacturing | 2,159 out of 5,695 | 62nd |
Major group Chemicals And Allied Products | 778 out of 2,194 | 65th |
Industry group Drugs | 655 out of 1,880 | 65th |
Industry In Vitro and In Vivo Diagnostic Substances | 14 out of 77 | 82nd |
Source: SEC filing on May 26, 2020.
Andrews' colleagues
We found five more compensation records of executives who worked with Ronald Andrews at Oncocyte Corp in 2019.
2019
William Annett
Oncocyte Corp
Chief Executive Officer
2019
Lyndal Hesterberg
Oncocyte Corp
Chief Scientific Officer
2019
Mitchell Levine
Oncocyte Corp
Chief Financial Officer
2019
Albert Parker
Oncocyte Corp
Chief Operating Officer
2019
Padma Sundar
Oncocyte Corp